Elisity

76% of healthcare leaders say it is highly important that a microsegmentation solution avoids disruption to clinical or operational workflows.

34% of healthcare leaders cite insufficient internal staff or specialized security resources to implement and manage microsegmentation as a barrier.

40% of healthcare leaders cite concerns about disrupting clinical workflows or patient care during deployment as a barrier to implementing microsegmentation.

54% of healthcare leaders cite policy-management overhead as a critical or significant limitation.

52% of healthcare leaders cite lack of continuous monitoring for lateral movement and segmentation failures as a critical or significant limitation.

42% of healthcare leaders state that reducing incident response and breach remediation costs is one of the most important ROI outcomes when considering microsegmentation investments.

62% of healthcare leaders rate their organization's inability to protect unpatchable or agentless devices as a critical or significant limitation—the highest-rated limitation.

30% of healthcare leaders report poor visibility into device inventory as a key limitation.

56% of healthcare leaders report poor visibility of devices and asset inventory as a critical or significant limitation.

32% of healthcare leaders cite long rollout timelines as a barrier to implementing microsegmentation.

30% of healthcare leaders cite the complexity of integrating with multi-vendor network infrastructure across sites as a barrier to implementing microsegmentation.

Nearly half of healthcare leaders say their cyber insurance carrier requested specific controls during renewal or underwriting in the last two years.

60% of healthcare leaders flag their organization's inability to protect unpatchable or agentless devices as a critical or significant limitation.